NASDAQ · Biotechnology

Voyager Therapeutics, Inc. (VYGR) Stock

$2.45 +3.38% NASDAQ: VYGR Healthcare

Valuation

MetricValue
Price$2.45
Market Cap$148.03M
P/E Ratio-1.35
P/B Ratio0.96
P/S Ratio4.30
EPS (TTM)$-2.04
52-Week High$5.55
52-Week Low$2.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-57.92%
ROA-54.48%
ROCE-64.72%
Gross Margin-330.00%
Operating Margin-330.00%
Net Margin-312.63%
Debt/Equity0.21
Current Ratio7.52

Annual Financials (USD)

Metric20212022202320242025
Revenue$37.0M$41.0M$250.0M$80.0M$40.0M
Operating Profit$-74.0M$-51.0M$122.0M$-83.0M$-132.0M
Net Profit$-71.0M$-46.0M$132.0M$-65.0M$-120.0M
EPS$-1.75$-1.21$2.97$-1.13$-2.04
Op Margin-196.8%-124.3%48.8%-104.1%-326.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$194.0M$159.0M$351.0M$393.0M$252.0M
Total Liabilities$99.0M$100.0M$115.0M$93.0M$56.0M
Cash$117.0M$99.0M$69.0M$71.0M$65.0M
Borrowings$44.0M$23.0M$20.0M$44.0M$36.0M

Latest News

Voyager Therapeutics Expects to Start Early Alzheimer's Study in Adults in H2 MT Newswires · Jul 13, 2026 Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026 GlobeNewswire · Jul 13, 2026 Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer’s? Barrons.com · Jul 13, 2026 Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money 24/7 Wall St. · Jul 2, 2026 Voyager Therapeutics (VYGR) is Amongst the Best Stocks Under $10, With More Than 50% Upside Insider Monkey · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-54.0M$-13.0M$78.0M$-15.0M$-132.0M
Investing Cash Flow$64.0M$-10.0M$-145.0M$-98.0M$123.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$13.0M$-18.0M$-30.0M$4.0M$-6.0M
Free Cash Flow$-55.0M$-15.0M$75.0M$-19.0M$-135.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.76
EV / EBITDA-1.41
FCF Yield-82.02%
Quick Ratio7.51
Interest Coverage0.00
Return 1Y-7.87%
Return 3Y-66.77%
Return 5Y-8.93%

Ownership

Insiders Held15.14%
Institutions Held56.31%
Institutions Float Held66.35%
Institutional HolderSharesReport Date
Blackrock Inc.5,568,3812026-03-31
Armistice Capital, LLC3,500,0002026-03-31
Millennium Management Llc3,428,5712026-03-31
Vestal Point Capital, LP3,002,9362026-03-31
Vanguard Capital Management LLC2,283,2532026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. is led by CEO Alfred W. Sandrock Jr., publicly traded since 2015.

Voyager Therapeutics, Inc. (VYGR) stock trades at $2.45 with a market capitalization of $148.03M. The stock is valued at a price-to-earnings (P/E) ratio of -1.35, price-to-book of 0.96, price-to-sales of 4.30. Over the past 52 weeks the stock has ranged between $2.36 and $5.55, and currently trades 55.9% below its 52-week high.

On profitability, Voyager Therapeutics, Inc. generates a return on equity (ROE) of -57.92%, return on capital employed of -64.72%, an operating margin of -330.00%, a net profit margin of -312.63%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides